← Open Payments lookup

ROBERT IMANI: Open Payments

NPI 1639374747 · LANCASTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,452 in 57 payments from 11 companies in 2025. Trend: 2023 $1,667 · 2024 $1,544 · 2025 $1,452

Food & beverage: $1,452
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.16$475
Takeda Pharmaceuticals U.S.A., Inc.9$223
Lundbeck LLC8$192
E.R. Squibb & Sons, L.L.C.8$167
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$150
ABBVIE INC.4$100
Alkermes, Inc.2$53
Axsome Therapeutics, Inc.1$28
Corium, LLC1$23
Neos Therapeutics, LP1$22

Products named: REXULTI, TRINTELLIX, COBENFY, CAPLYTA, VRAYLAR, ABILIFY ASIMTUFII, ARISTADA, Auvelity.

Industry payments across CA — which companies pay providers there.